Press release: Pioneering the Future of Antibody Discovery with Salipro Biotech and Bio-Rad

In this press release, Bio-Rad highlights our successful collaboration where we leverage our Salipro® platform with Bio-Rad’s Pioneer™ Antibody Discovery Platform to develop high-quality human antibody leads against challenging GPCR targets. 

The results are exciting, with the new antibodies exhibiting functional activity and offering the potential for new therapeutic avenues.

We are proud to be part of this groundbreaking work and to contribute to the development of novel and more effective treatments in the field of immuno-oncology.

Read more about Bio-Rad's press release here.